Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine

  title={Interleukin‐6 Serum Levels in Depressed Patients before and after Treatment with Fluoxetine},
  author={A. Służewska and J. Rybakowski and M. Laciak and A. Mackiewicz and M. Sobieska and K. Wiktorowicv},
  journal={Annals of the New York Academy of Sciences},

Topics from this paper

Religious participation, interleukin-6, and mortality in older adults.
Findings are consistent with a role for IL-6 in processes mediating the relationship between religious attendance and mortality, and Structural equation modeling indicated religious attendance was significantly related to lower mortality rates and interleukin-6 levels, and IL- 6 levels mediated the prospective relationship between religion and mortality. Expand
Depression after Myocardial Infarction
Questions about the pathophysiologic mechanism of depression in this setting are paralleled by uncertainties about the optimal treatment of depression for patients recovering from a myocardial infarction and by a lack of knowledge about whether treating depression lowers the associated increased mortality risk. Expand
Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia
Findings show that increased sIL-1RA, sTNF-R1, and TBARS levels may be trait markers of depression, while increased sil-6R Levels may be a state marker of melancholia and an acute phase of depression. Expand
Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection
The purpose of this study was to characterize hepatitis C virus (HCV)‐associated differences in the expression of 47 inflammatory factors and to evaluate the potential role of peripheral immuneExpand
The Effect of Antidepressant Medication Treatment on Serum Levels of Inflammatory Cytokines: A Meta-Analysis
Overall, while pharmacological antidepressant treatment reduced depressive symptoms, it did not reduce serum levels of TNFα, but antidepressant treatment did reduce levels of IL-1β and possibly those ofIL-6, which are consistent with the possibility that inflammatory cytokines contribute to depressive symptoms and that antidepressants block the effects ofinflammatory cytokines on the brain. Expand
Cytokines as a stressor: implications for depressive illness.
An overview of the neurochemical sequelae of acute and repeated interleukin-1beta, tumour necrosis factor-alpha (TNF-alpha) and IL-2 treatment is provided, and it is suggested that cytokines may impact on emotional changes, including depression. Expand
Cytokine Production and Treatment Response in Major Depressive Disorder
The data indicate that unstimulated secretion of TNF-α is related to the psychopathological improvement; whereas, IL-6 levels might dichotomize the patients into subsequent responders and nonresponders already at admission. Expand
Indicators of immune activation in major depression
The correlations between cytokines and acute phase proteins studied point to a significant role of elevated IL-6 secretion in the induction of Type I AGP microheterogeneity changes that are characteristic of some inflammatory conditions. Expand
Anti-TNF-α Compounds as a Treatment for Depression
This mini-review summarizes the results of studies that examined the mood-modulating effects of anti-TNF-α drugs and indicates that selective anti- TNF- α compounds were tested as a potential therapeutic strategy for mood disorders. Expand
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
Fluoxetine is proposed as an adjuvant therapeutic agent for COVID-19 based on its known immunomodulatory, anti-inflammatory and antiviral properties and may potentially reduce pro-inflammatory chemokine/cytokines levels in CO VID-19 patients. Expand


Haptoglobin phenotypes and gene frequencies in unipolar major depression.
Major depression is characterized by a hyperhaptoglobinemia that is largely independent of haptoglobin phenotypes, which suggests that genetic variation on chromosome 16 may be associated with that illness. Expand
Elevated plasma concentrations of alpha 1-acid glycoprotein, a putative endogenous inhibitor of the tritiated imipramine binding site, in depressed patients.
There was a significant positive correlation between plasma concentrations of alpha 1-acid glycoprotein and postdexamethasone plasma cortisol concentrations, and two measures of depression severity, the Montgomery-Asberg Rating Scale for Depression and the Center for Epidemiologic Studies-Depression Scale, and a significant negative correlation with age. Expand